Related Experiment Video

Updated: Jul 15, 2026

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

The differential regulation of Smad7 in kidney tubule cells by connective tissue growth factor and transforming

Weier Qi1, Xinming Chen, Stephen Twigg

  • 1Kolling Institute, Department of Medicine, Royal North Shore Hospital and University of Sydney, Sydney, New South Wales, Australia.

Nephrology (Carlton, Vic.)
|May 15, 2007
PubMed
Abstract

Insights

Transforming growth factor-beta1 (TGF-beta1) rapidly induces Smad7, a key regulator of TGF-beta signaling. Connective tissue growth factor (CTGF) diminishes Smad7 levels, thereby promoting TGF-beta1 activity in renal cells.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Renal physiology

Background:

  • Smad7 is an inhibitory Smad protein regulating transforming growth factor-beta (TGF-beta) signaling.
  • Connective tissue growth factor (CTGF) mediates TGF-beta1's fibrogenic effects.
  • The interplay between CTGF, Smad7, and TGF-beta1 in renal tubular cells is not well understood.

Purpose of the Study:

  • To investigate the effect of CTGF on Smad7 expression.
  • To elucidate CTGF's role in TGF-beta1-induced Smad7 regulation in renal tubular cells.

Main Methods:

  • Utilized human proximal tubular (HK-2) cells and a diabetic rat model.
  • Employed RT-PCR to quantify Smad7, TGF-beta1, and Smad2 mRNA levels.
  • Used siRNA to silence CTGF or TGF-beta1 expression in HK-2 cells.
  • Measured active TGF-beta1 levels via ELISA.

Main Results:

  • TGF-beta1 rapidly induced Smad7 expression in a time-dependent manner.
  • CTGF significantly reduced Smad7 expression, an effect observed within 24 hours.
  • In vivo data showed increased CTGF and decreased Smad7 in diabetic rats.
  • Silencing TGF-beta1 reduced basal Smad7, while silencing CTGF increased basal Smad7 and potentiated TGF-beta1's effect.
  • CTGF silencing decreased TGF-beta1 and Smad2 levels.

Conclusions:

  • Smad7 is rapidly induced by TGF-beta1, acting as a negative feedback mechanism.
  • CTGF promotes TGF-beta1 activity by reducing Smad7 availability and increasing Smad2 levels.
  • These findings highlight a novel regulatory pathway involving CTGF, Smad7, and TGF-beta1 in renal physiology.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Glomerular Filtration Rate and its Regulation01:28

Glomerular Filtration Rate and its Regulation

The Glomerular Filtration Rate (GFR) is a measure of kidney function, reflecting the volume of filtrate formed per minute in the kidneys. On average, GFR is approximately 125 mL/min in males and 105 mL/min in females. Maintaining a relatively constant GFR is essential for the kidneys to effectively regulate body fluid homeostasis and maintain extracellular stability.
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...